John Stuelpnagel - Director, 10x Genomics, Inc

As of October 20, 2021


John Stuelpnagel Net Worth

  • Net worth is estimated to be at least $426.92M
  • Owns at least 361,616 units of 10x Genomics, Inc stock
  • Sold an estimated value of $33.87M in the last 2 years at 10x Genomics, Inc

John Stuelpnagel Trading

  • Largest sale of shares was 7,500 units , worth over $1.45M on February 18, 2021
  • In total has made about 36 transactions over 2 years
  • Usually trades in September and June, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John Stuelpnagel Mailing Address

  • Mailing address is 10x Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 CA

10x Genomics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Serge Saxonov 2020 $400,000 $ $ $10,227,724 $ $254,993 $10,882,717
Serge Saxonov 2019 $393,750 $ $ $1,811,712 $157,500 $ $2,362,962
Serge Saxonov 2018 $365,833 $ $ $601,010 $117,432 $ $1,084,275
Justin J. McAnear 2020 $330,000 $ $ $3,933,816 $ $ $4,263,816
Justin J. McAnear 2019 $325,000 $18,688 $ $248,561 $56,062 $ $648,311
Justin J. McAnear 2018 $71,737 $ $ $1,455,118 $ $ $1,526,855
Benjamin J. Hindson 2020 $350,000 $ $ $5,900,537 $ $264,974 $6,515,511
Benjamin J. Hindson 2019 $342,750 $24,635 $ $1,242,677 $59,124 $ $1,669,186
Bradford J. Crutchfield 2020 $350,000 $ $ $3,933,649 $ $ $4,283,649
Ruth De Backer 2020 $237,808 $ $4,345,338 $6,288,253 $ $100,000 $10,971,399
Ruth De Backer 2019 $334,902 $24,071 $ $1,056,276 $57,771 $ $1,473,020
Ruth De Backer 2018 $316,340 $21,748 $ $480,845 $55,850 $ $874,783
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1770787/000177078721000024/txg-2021def14a.htm

10x Genomics, Inc Insider Trading

  • The most recent transaction was 5,000 units sold on October 20, 2021 by John Stuelpnagel worth over $753.34K
  • In the last 2 years, insiders at 10x Genomics, Inc sold an estimated value of $805.17M and bought an estimated value of $23.64M
  • The most active traders are John Stuelpnagel, Director,  Serge Saxonov, Chief Executive Officer,  and Benjamin Hindson, See Remarks
  • Insider trading is most common in September, with the busiest year in 2020

10x Genomics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1